Concepedia

Author

Kazuoki Kondo

Mitsubishi Tanabe Pharma Corporation

Also Known As

K Kondo, K. Kondo, KAZUOKI KONDO, Kazuoki KONDO, Kazuoki Kondo, Kondo, K., Koyo Kondo

169

Publications

5K

Citations

30

H-Index

72

Concepts

All Affiliations

Mitsubishi Tanabe Pharma CorporationKeio UniversityMitsubishi Group (Japan)The University of TokyoKyoto University
KK

About

Kazuoki Kondo is an author at Mitsubishi Tanabe Pharma Corporation specializing in medicine, physiology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

35

2.7K

2

Health Sciences

2

2

44

3

Anesthesia

2

2

38

4

Social Sciences

1

1

16

5

Allergy

1

1

35

Kazuoki Kondo

×

67

Publications

3.8K

Citations

29

H-Index

YearCitations

Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial

Koji Abe, Masashi Aoki, Shoji Tsuji,

The Lancet Neurology

2017

900

Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients

Koji Abe, Yasuto Itoyama, Gen Sobue,

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

2014

348

Multiple Factors Contribute to the Pathogenesis of Hypertension in Cushing's Syndrome

Takao Saruta, Hiromichi Suzuki, Michiko Handa,

The Journal of Clinical Endocrinology & Metabolism

1986

204

Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double‐blind, placebo‐controlled, 12‐week study

Nobuya Inagaki, Kazuoki Kondo, Toru Yoshinari,

Diabetes Obesity and Metabolism

2013

134

Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study

Nobuya Inagaki, Kazuoki Kondo, Toru Yoshinari,

Expert Opinion on Pharmacotherapy

2014

120

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease

Toshifumi Hibi∥, Shunsei Hirohata, Hirotoshi Kikuchi,

Medicine

2016

119

Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS)

Yukito Shinohara, K Nishimaru, Tohru Sawada,

Stroke

2008

112

Serum Uric Acid and the Renin‐Angiotensin System in Hypertension

Ikuo Saito, T Saruta, Kazuoki Kondo,

Journal of the American Geriatrics Society

1978

96

Efficacy, safety and dose–response relationship of teneligliptin, a dipeptidyl peptidase‐4 inhibitor, in Japanese patients with type 2 diabetes mellitus

Takashi Kadowaki, Kazuoki Kondo

Diabetes Obesity and Metabolism

2013

84

Central renin-angiotensin system and the pathogenesis of DOCA-salt hypertension in rats

Yoshiaki Itaya, Hisanori Suzuki, S Matsukawa,

American Journal of Physiology-Heart and Circulatory Physiology

1986

84

Page 1